CD 161

• Description:

  A potent, selective, orally bioavailable BET bromodomain inhibitor with IC50 of 7.2 and 28.2 nM for BRD4 BD2 and BRD4 BD1, respectively.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  435.487

• Molecular Formula:

  C26H21N5O2

• Notes:

  Research use only, not for human use.

• Receptor:

  Bromodomain

• CAS Number:

  1627716-22-6